Andrew Schiff, Director at Zeltiq Aesthetics, holds 443.62K shares in Aclaris Therapeutics (Ticker: ACRS), holds 2.10M shares in Zeltiq Aesthetics (Ticker: ZLTQ), holds ― shares in Monte Rosa Therapeutics (Ticker: GLUE).
What is the percentage of profitable transactions made by Andrew Schiff?
The percentage of profitable transactions made by Andrew Schiff is 25%.
What is the average return per transaction made by Andrew Schiff?
The average return per transaction made by Andrew Schiff is -10.90%.
What stocks does Andrew Schiff hold?
Andrew Schiff holds: ZLTQ, ACRS, GLUE, AGRX stocks.
What was Andrew Schiff’s latest transaction?
Andrew Schiff latest transaction was an Uninformative Buy of $4.80K.
What was Andrew Schiff's most profitable transaction?
Andrew Schiff’s most profitable transaction was an Informative Buy of AGRX stock on May 28, 2014. The return on the trade was 67.40%.
What is Andrew Schiff's role in Zeltiq Aesthetics?
Andrew Schiff's role in Zeltiq Aesthetics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.